Apotex acquires US rights to PROVIGIL® (modafinil) and NUVIGIL® (armodafinil)
TORONTO, Jan. 9, 2025 /PRNewswire/ - Apotex Inc. ("Apotex"), the largest Canadian-based pharmaceutical company, today announced that its affiliate Nuvo Pharmaceuticals (Ireland) DAC has acquired the United States rights to